JIM
LXRX icon

Jupiter Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jupiter Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-80,955
Closed -$157K – 449
2020
Q1 		$157K Buy
+80,955
New +$241K ﹤0.01% 350
2017
Q2 		– Sell
-421,242
Closed -$6.04M – 445
2017
Q1 		$6.04M Buy
421,242
+116,513
+38% +$1.73M 0.09% 152
2016
Q4 		$4.21M Buy
304,729
+89,724
+42% +$1.44M 0.07% 153
2016
Q3 		$3.88M Buy
215,005
+197,057
+1,098% +$3.17M 0.07% 176
2016
Q2 		$257K Buy
+17,948
New +$243K ﹤0.01% 362

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jupiter Investment Management's LXRX Position: Q2 2020 in Review

Jupiter Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2020, closing a stake of 80,955 shares — an estimated $157K sold.

Jupiter Investment Management first reported a position in LXRX in Q2 2016 and held it in 5 quarters. The position peaked at $6.04M in Q1 2017. 108 funds tracked by Wall St. Rank hold LXRX as of Q2 2020.

  • Jupiter Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Jupiter Investment Management sold 80,955 Lexicon Pharmaceuticals shares in Q2 2020, an estimated $157K.
  • Jupiter Investment Management first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 5 quarters.
  • Jupiter Investment Management's Lexicon Pharmaceuticals position peaked at $6.04M in Q1 2017.
  • 108 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.